Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Nova Biomedical

Nova is a world leader in the development and manufacturing of whole blood, point-of-care and critical care analyzers... read more Featured Products: More products

Download Mobile App





Nova Biomedical Showcases Advanced Point-of-Care Capillary Blood Analyzers at MEDLAB Middle East 2021

By LabMedica International staff writers
Posted on 22 Jun 2021
Nova Biomedical (Waltham, MA, USA) showcased its advanced point-of-care (POC) capillary blood analyzers at MEDLAB Middle East 2021, alongside other products such as POC meters for glucose testing, renal function monitoring and lactate testing.

At this year’s MEDLAB Middle East, Nova exhibited the StatStrip Glucose, which is the only glucose meter cleared by the US FDA for use with critically ill patients, that achieves superior accuracy with no clinical interferences. More...
StatStrip is designed specifically to measure and correct for clinical interferences that can be present in critically ill patients. Nova also showcased the Stat Profile Prime Plus that combines blood gases, electrolytes, metabolites, CO-Oximetry, and 34 calculated results in a simple, compact critical care blood gas analyzer. Prime Plus combines maintenance-free, component cartridge technology for sensors and reagents with patented, new, maintenance-free, and non-lysing whole blood CO-Oximetry technology.

In addition, Nova showcased Allegro, a compact, point-of-care (POC) analyzer that features a clinically important menu of 10 measured and individually selectable tests, plus seven calculated tests. All tests are measured with disposable, ready-to-use cartridges or test strips, and are easily performed by non-technical personnel. Allegro uses a very small capillary blood drop for all blood tests, which eliminates the need for venipunctures or a trained phlebotomist. With cartridge test times of six to nine minutes and the ability to measure two cartridges simultaneously, Allegro provides rapid results.

Also on display at the event was the EMS Stat, a portable system for A&E use for GLU, KET, LAC, Hb, and HCT testing. Stat EMS can measure lactate, hematocrit, hemoglobin, glucose, and ketone from a capillary blood drop. Results are available in seconds by using single-use biosensors and portable meters. Stat EMS offers simple, fast, and accurate testing in the field. These tests can also help determine the appropriate transport site for patients with trauma, sepsis, or other specialized needs.

Related Links:
Nova Biomedical


New
Gold Member
Genetic Type 1 Diabetes Risk Test
T1D GRS Array
POC Helicobacter Pylori Test Kit
Hepy Urease Test
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Automatic Hematology Analyzer
DH-800 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The new diagnostic platform aims to detect lymphatic disease earlier and more precisely (Photo courtesy of 123RF)

Diagnostic Toolbox to Rapidly and Reliably Detect Lymphatic Disease

The lymphatic system plays a crucial role in fluid balance and immune defense, but remains one of the hardest systems in the body to diagnose when it malfunctions. Because lymphatic vessels are tiny, translucent,... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.